Have a feature idea you'd love to see implemented?
Let us know!
CDNA CareDx Inc
Price (delayed)
$30.91
Market cap
$1.63B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.98
Enterprise value
$1.56B
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant
Highlights
The debt has declined by 17% year-on-year and by 6% since the previous quarter
The company's gross margin rose by 3.3% QoQ
CareDx's EPS has plunged by 90% YoY but it has increased by 13% from the previous quarter
CareDx's net income has plunged by 90% YoY but it has increased by 13% from the previous quarter
The company's quick ratio fell by 16% YoY and by 4.3% QoQ
Key stats
What are the main financial stats of CDNA
Market
Valuations
Earnings
Shares outstanding
52.74M
Market cap
$1.63B
Enterprise value
$1.56B
Price to earnings (P/E)
N/A
Price to book (P/B)
6.08
Price to sales (P/S)
5.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.25
Revenue
$297.08M
EBIT
-$171.65M
EBITDA
-$151.39M
Free cash flow
-$21.41M
Per share
Balance sheet
Liquidity
EPS
-$2.98
Free cash flow per share
-$0.41
Book value per share
$5.08
Revenue per share
$5.69
TBVPS
$7.37
Total assets
$466.78M
Total liabilities
$202.11M
Debt
$25.39M
Equity
$264.67M
Working capital
$242.28M
Debt to equity
0.1
Current ratio
4.09
Quick ratio
3.77
Net debt/EBITDA
0.47
Margins
Efficiency
Dividend
EBITDA margin
-51%
Gross margin
65%
Net margin
-53.7%
Operating margin
-58.9%
Return on assets
-33.8%
Return on equity
-54.3%
Return on invested capital
-68%
Return on capital employed
-44.2%
Return on sales
-57.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CDNA stock price
How has the CareDx stock price performed over time
Intraday
1.54%
1 week
4.07%
1 month
11.67%
1 year
360.66%
YTD
157.58%
QTD
-1.01%
Financial performance
How have CareDx's revenue and profit performed over time
Revenue
$297.08M
Gross profit
$193.06M
Operating income
-$174.85M
Net income
-$159.64M
Gross margin
65%
Net margin
-53.7%
CareDx's operating margin has plunged by 106% YoY but it has increased by 18% from the previous quarter
The operating income has dropped by 98% year-on-year but it rose by 12% since the previous quarter
The net margin has dropped by 98% year-on-year but it has grown by 19% since the previous quarter
CareDx's net income has plunged by 90% YoY but it has increased by 13% from the previous quarter
Growth
What is CareDx's growth rate over time
Valuation
What is CareDx stock price valuation
P/E
N/A
P/B
6.08
P/S
5.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.25
CareDx's EPS has plunged by 90% YoY but it has increased by 13% from the previous quarter
The stock's price to book (P/B) is 176% more than its last 4 quarters average of 2.2 and 22% more than its 5-year quarterly average of 5.0
The equity has decreased by 35% YoY but it has increased by 3.3% from the previous quarter
The price to sales (P/S) is 159% more than the last 4 quarters average of 2.1 but 22% less than the 5-year quarterly average of 7.0
The revenue has increased by 8% QoQ but it has decreased by 4% YoY
Efficiency
How efficient is CareDx business performance
The ROE has plunged by 174% YoY but it has grown by 2.3% from the previous quarter
The ROIC has shrunk by 140% YoY but it rose by 7% QoQ
CDNA's return on assets has dropped by 114% year-on-year but it is up by 11% since the previous quarter
CareDx's ROS has plunged by 94% YoY but it has increased by 19% from the previous quarter
Dividends
What is CDNA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CDNA.
Financial health
How did CareDx financials performed over time
The company's total assets is 131% higher than its total liabilities
CareDx's total liabilities has soared by 84% YoY and by 3% from the previous quarter
The company's quick ratio fell by 16% YoY and by 4.3% QoQ
The debt is 90% smaller than the equity
The equity has decreased by 35% YoY but it has increased by 3.3% from the previous quarter
CareDx's debt to equity has increased by 25% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.